Nanostrategies to Develop Current Antiviral Vaccines.
ACS Appl Bio Mater
; 4(5): 3880-3890, 2021 05 17.
Article
in English
| MEDLINE | ID: covidwho-2278523
ABSTRACT
Infectious diseases are a worldwide concern. They are responsible for increasing the mortality rate and causing economic and social problems. Viral epidemics and pandemics, such as the COVID-19 pandemic, force the scientific community to consider molecules with antiviral activity. A number of viral infections still do not have a vaccine or efficient treatment and it is imperative to search for vaccines to control these infections. In this context, nanotechnology in association with the design of vaccines has presented an option for virus control. Nanovaccines have displayed an impressive immune response using a low dosage. This review aims to describe the advances and update the data in studies using nanovaccines and their immunomodulatory effect against human viruses.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Virus Diseases
/
Viral Vaccines
/
Nanomedicine
/
Vaccine Development
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
ACS Appl Bio Mater
Year:
2021
Document Type:
Article
Affiliation country:
Acsabm.0c01284
Similar
MEDLINE
...
LILACS
LIS